User:MarcoTolo/Sandbox4
From Wikipedia, the free encyclopedia
[edit] Summary
This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [1]
[edit] References
[edit] Further reading
- Eriksson JG (2007). "Gene polymorphisms, size at birth, and the development of hypertension and type 2 diabetes". J. Nutr. 137 (4): 1063-5. PMID 17374678.
- Cecil JE, Watt P, Palmer CN, Hetherington M (2006). "Energy balance and food intake: the role of PPARgamma gene polymorphisms". Physiol. Behav. 88 (3): 227-33. doi: . PMID 16777151.
- Rousseaux C, Desreumaux P (2006). "[The peroxisome-proliferator-activated gamma receptor and chronic inflammatory bowel disease (PPARgamma and IBD)]" (in French). J. Soc. Biol. 200 (2): 121-31. PMID 17151549.
- Gurnell M (2005). "Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies". Best Pract. Res. Clin. Endocrinol. Metab. 19 (4): 501-23. doi: . PMID 16311214.
- Pégorier JP (2005). "[PPAR receptors and insulin sensitivity: new agonists in development]" (in French). Ann. Endocrinol. (Paris) 66 (2 Pt 2): 1S10-7. PMID 15959400.
- Tsai YS, Maeda N (2005). "PPARgamma: a critical determinant of body fat distribution in humans and mice". Trends Cardiovasc. Med. 15 (3): 81-5. doi: . PMID 16039966.
- Cuzzocrea S (2004). "Peroxisome proliferator-activated receptors gamma ligands and ischemia and reperfusion injury". Vascul. Pharmacol. 41 (6): 187-95. doi: . PMID 15653094.
- Rangwala SM, Lazar MA (2004). "Peroxisome proliferator-activated receptor gamma in diabetes and metabolism". Trends Pharmacol. Sci. 25 (6): 331-6. doi: . PMID 15165749.
- Takano H, Hasegawa H, Nagai T, Komuro I (2003). "The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy". Drugs Today 39 (5): 347-57. PMID 12861348.
- Puigserver P, Spiegelman BM (2003). "Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator". Endocr. Rev. 24 (1): 78-90. PMID 12588810.
- Koeffler HP (2003). "Peroxisome proliferator-activated receptor gamma and cancers". Clin. Cancer Res. 9 (1): 1-9. PMID 12538445.
- Stumvoll M, Häring H (2002). "The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism". Diabetes 51 (8): 2341-7. PMID 12145143.
- Takano H, Komuro I (2002). "Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease". J. Diabetes Complicat. 16 (1): 108-14. PMID 11872377.
- Wakino S, Law RE, Hsueh WA (2002). "Vascular protective effects by activation of nuclear receptor PPARgamma". J. Diabetes Complicat. 16 (1): 46-9. PMID 11872366.
- Kadowaki T, Hara K, Kubota N, et al (2002). "The role of PPARgamma in high-fat diet-induced obesity and insulin resistance". J. Diabetes Complicat. 16 (1): 41-5. PMID 11872365.
- Qi C, Zhu Y, Reddy JK (2000). "Peroxisome proliferator-activated receptors, coactivators, and downstream targets". Cell Biochem. Biophys. 32 Spring: 187-204. PMID 11330046.